These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38928701)

  • 1. Comparative Analysis of Lymphocyte Populations in Post-COVID-19 Condition and COVID-19 Convalescent Individuals.
    Berger L; Wolf J; Kalbitz S; Kellner N; Lübbert C; Borte S
    Diagnostics (Basel); 2024 Jun; 14(12):. PubMed ID: 38928701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 spike antigen-specific B cell and antibody responses in pre-vaccination period COVID-19 convalescent males and females with or without post-covid condition.
    Limoges MA; Quenum AJI; Chowdhury MMH; Rexhepi F; Namvarpour M; Akbari SA; Rioux-Perreault C; Nandi M; Lucier JF; Lemaire-Paquette S; Premkumar L; Durocher Y; Cantin A; Lévesque S; Dionne IJ; Menendez A; Ilangumaran S; Allard-Chamard H; Piché A; Ramanathan S
    Front Immunol; 2023; 14():1223936. PubMed ID: 37809081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection.
    Ryan FJ; Hope CM; Masavuli MG; Lynn MA; Mekonnen ZA; Yeow AEL; Garcia-Valtanen P; Al-Delfi Z; Gummow J; Ferguson C; O'Connor S; Reddi BAJ; Hissaria P; Shaw D; Kok-Lim C; Gleadle JM; Beard MR; Barry SC; Grubor-Bauk B; Lynn DJ
    BMC Med; 2022 Jan; 20(1):26. PubMed ID: 35027067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential decline of SARS-CoV-2-specific antibody levels, innate and adaptive immune cells, and shift of Th1/inflammatory to Th2 serum cytokine levels long after first COVID-19.
    Kratzer B; Gattinger P; Trapin D; Ettel P; Körmöczi U; Rottal A; Stieger RB; Sehgal ANA; Feichter M; Borochova K; Tulaeva I; Grabmeier-Pfistershammer K; Tauber PA; Perkmann T; Fae I; Wenda S; Kundi M; Fischer GF; Valenta R; Pickl WF
    Allergy; 2024 Jul; ():. PubMed ID: 39003594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Event rates and incidence of post-COVID-19 condition in hospitalised SARS-CoV-2 positive children and young people and controls across different pandemic waves: exposure-stratified prospective cohort study in Moscow (StopCOVID).
    Pazukhina E; Rumyantsev M; Baimukhambetova D; Bondarenko E; Markina N; El-Taravi Y; Petrova P; Ezhova A; Andreeva M; Iakovleva E; Bobkova P; Pikuza M; Trefilova A; Abdeeva E; Galiautdinova A; Filippova Y; Bairashevskaia A; Zolotarev A; Bulanov N; DunnGalvin A; Chernyavskaya A; Kondrikova E; Kolotilina A; Gadetskaya S; Ivanova YV; Turina I; Eremeeva A; Fedorova LA; Comberiati P; Peroni DG; Nekliudov N; Genuneit J; Reyes LF; Brackel CLH; Mazankova L; Miroshina A; Samitova E; Borzakova S; Carson G; Sigfrid L; Scott JT; McFarland S; Greenhawt M; Buonsenso D; Semple MG; Warner JO; Olliaro P; Osmanov IM; Korsunskiy AA; Munblit D;
    BMC Med; 2024 Feb; 22(1):48. PubMed ID: 38302974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal Observation of Immune Response for 23 Months in COVID-19 Convalescent Patients After Infection and Vaccination.
    Xu J; Zheng J; Tan Y; Cai J; Xiang Y; Ling H; Li Z; Bai Q
    Viral Immunol; 2023; 36(6):389-400. PubMed ID: 37276049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogenous CD8+ T Cell Maturation and 'Polarization' in Acute and Convalescent COVID-19 Patients.
    Kudryavtsev IV; Arsentieva NA; Korobova ZR; Isakov DV; Rubinstein AA; Batsunov OK; Khamitova IV; Kuznetsova RN; Savin TV; Akisheva TV; Stanevich OV; Lebedeva AA; Vorobyov EA; Vorobyova SV; Kulikov AN; Sharapova MA; Pevtsov DE; Totolian AA
    Viruses; 2022 Aug; 14(9):. PubMed ID: 36146713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated complement C3 and increased CD8 and type 1 helper lymphocyte T populations in patients with post-COVID-19 condition.
    Garcia-Gasalla M; Berman-Riu M; Rodriguez A; Iglesias A; Fraile-Ribot PA; Toledo-Pons N; Pol-Pol E; Ferré-Beltrán A; Artigues-Serra F; Martin-Pena ML; Pons J; Murillas J; Oliver A; Riera M; Ferrer JM
    Cytokine; 2023 Sep; 169():156295. PubMed ID: 37453328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody tests for identification of current and past infection with SARS-CoV-2.
    Fox T; Geppert J; Dinnes J; Scandrett K; Bigio J; Sulis G; Hettiarachchi D; Mathangasinghe Y; Weeratunga P; Wickramasinghe D; Bergman H; Buckley BS; Probyn K; Sguassero Y; Davenport C; Cunningham J; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Struyf T; Van den Bruel A; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Deeks JJ;
    Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013652. PubMed ID: 36394900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remodeling of T Cell Dynamics During Long COVID Is Dependent on Severity of SARS-CoV-2 Infection.
    Wiech M; Chroscicki P; Swatler J; Stepnik D; De Biasi S; Hampel M; Brewinska-Olchowik M; Maliszewska A; Sklinda K; Durlik M; Wierzba W; Cossarizza A; Piwocka K
    Front Immunol; 2022; 13():886431. PubMed ID: 35757700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mild and Asymptomatic COVID-19 Convalescents Present Long-Term Endotype of Immunosuppression Associated With Neutrophil Subsets Possessing Regulatory Functions.
    Siemińska I; Węglarczyk K; Surmiak M; Kurowska-Baran D; Sanak M; Siedlar M; Baran J
    Front Immunol; 2021; 12():748097. PubMed ID: 34659245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the Long-Term Impact on Cellular Immunity in COVID-19-Recovered Individuals Reveals a Profound NKT Cell Impairment.
    Liu J; Yang X; Wang H; Li Z; Deng H; Liu J; Xiong S; He J; Feng X; Guo C; Wang W; Zelinskyy G; Trilling M; Sutter K; Senff T; Menne C; Timm J; Zhang Y; Deng F; Lu Y; Wu J; Lu M; Yang D; Dittmer U; Wang B; Zheng X
    mBio; 2021 Apr; 12(2):. PubMed ID: 33906918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of changes in immune status linked to COVID-19 convalescent and its clinical severity in patients and uninfected exposed relatives.
    Torres Rives B; Zúñiga Rosales Y; Mataran Valdés M; Roblejo Balbuena H; Martínez Téllez G; Rodríguez Pérez J; Caridad Marín Padrón L; Rodríguez Pelier C; Sotomayor Lugo F; Valdés Zayas A; Carmenate Portilla T; Sánchez Ramírez B; Carlos Silva Aycaguer L; Portal Miranda JA; Marcheco Teruel B
    Immunobiology; 2022 May; 227(3):152216. PubMed ID: 35436751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status.
    Neidleman J; Luo X; McGregor M; Xie G; Murray V; Greene WC; Lee SA; Roan NR
    Elife; 2021 Oct; 10():. PubMed ID: 34636722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mRNA-based SARS-CoV-2 Comirnaty vaccine elicits weak and short specific memory B cell response in individuals with no previous infection.
    Casado JL; Vizcarra P; Martín-Hondarza A; Gómez-Maldonado S; Muedra-Sánchez M; Del Pino J; Mirabella IG; Martín-Colmenarejo S; Haemmerle J; Fernández-Escribano M; Vallejo A
    Front Immunol; 2023; 14():1127379. PubMed ID: 37457694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recovering or Persisting: The Immunopathological Features of SARS-CoV-2 Infection in Children.
    Buonsenso D; Valentini P; De Rose C; Tredicine M; Pereyra Boza MDC; Camponeschi C; Morello R; Zampino G; Brooks AES; Rende M; Ria F; Sanguinetti M; Delogu G; Sali M; Di Sante G; On Behalf Of The Gemelli-Pediatric Covid-Team
    J Clin Med; 2022 Jul; 11(15):. PubMed ID: 35955979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired adaptive immune response in COVID-19 convalescent patients with hematological malignancies.
    Kalicińska E; Szymczak D; Andrasiak I; Milanowska A; Kiraga A; Majeranowski A; Jabłonowska P; Rybka J; Maciej Z; Wróbel T
    Eur J Haematol; 2023 Apr; 110(4):396-406. PubMed ID: 36562254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of Long-Lasting Humoral and Cellular Immunity against SARS-CoV-2 Even in Elderly COVID-19 Convalescents Showing a Mild to Moderate Disease Progression.
    Fischer B; Lindenkamp C; Lichtenberg C; Birschmann I; Knabbe C; Hendig D
    Life (Basel); 2021 Aug; 11(8):. PubMed ID: 34440549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody tests for identification of current and past infection with SARS-CoV-2.
    Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Treatment With Nirmatrelvir and the Risk of Post-COVID-19 Condition.
    Xie Y; Choi T; Al-Aly Z
    JAMA Intern Med; 2023 Jun; 183(6):554-564. PubMed ID: 36951829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.